Prescription Drug Monitoring Program:
Provides that when controlled substance listed as Schedule II substance is dispensed or released, in addition to other identification procedures, fingerprint may be collected; provides exceptions.
July 1, 2012
Died in Health & Human Services Quality Subcommittee on Friday, March 9, 2012 11:59 PM
(*) Not the latest version